Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Open accessAbstract
BACKGROUND: Obese women with polycystic ovary syndrome (PCOS) may face additional barriers in achieving weight loss. We aimed to compare the effects of the hypocaloric low glycemic index (LGI) diet on anthropometric variables and insulin resistance in women with and without PCOS and investigate the effect of this diet on the clinical and hormonal features of PCOS women. METHODS: This interventional study was carried out at the Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Of 108 women invited for the purpose of the present study, 62 participants (PCOS = 28, non-PCOS = 34) followed a 24-week energy restricted LGI diet. Anthropometric, biochemical, hormonal and clinical measurements were documented at baseline, 12 weeks and 24 weeks with intervention. RESULTS: The percentages of weight loss achieved by both the PCOS and non-PCOS groups did not differ significantly (PCOS: -8.04% vs. non-PCOS: -8.09%). No significant difference in decrease of homeostatic model assessment of insulin resistance (HOMA-IR) was observed between the two groups (PCOS = - 0.83 ± 0.33, non PCOS = - 0.79 ± 0.28, P = 0.83). In PCOS women, significant reduction in total testosterone (- 0.91 ± 0.33 nmol/L, P = 0.006), FAI (- 4.47 ± 1.1, P < 0.001) and increase in SHBG (38.98 ± 11.02 nmol/L, P < 0.001) were observed. Menstrual irregularity was improved in 80% of women with PCOS and a significant decrease (32.1%) in occurrence of acne was reported. CONCLUSIONS: This diet has equally beneficial effects on anthropometric and metabolic characteristics of overweight women with and without PCOS. TRIAL REGISTRATION: This study is registered in the Iranian Randomized Clinical Trials Registry (IRCT, code: IRCT2016092129909N1 ).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies lacked a control group, used different measures of cardiometabolic risk, and had an inability to determine what is driving the relationship of improvement in cardiometabolic risk factors.
“include the lack of a control group [97,98], different measures of cardiometabolic risk [96], and the inability to determine what is driving the relationship of the improvement in cardiometabolic risk factors”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [96]
The citing sentence attributes a lack of a control group to the studies cited at that point. This paper says the opposite in Discussion, “Strengths and limitations” (page unavailable): it identifies having a control group as a study strength. That section lists other measurement limitations, but does not describe the study as lacking controls. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · see citing works
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · see citing works
Glycemic index and glycemic load: measurement issues and their effect on diet–disease relationships
Venn, B. J., & Green, T. J. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602942 · Cited by 395 · see citing works
Teede, H. J., Joham, A. E., Paul, E., Moran, L. J., Loxton, D., Jolley, D., & Lombard, C. (2013) · Obesity · doi:10.1002/oby.20213 · Cited by 351 · see citing works
Robinson, S., Chan, S., Spacey, S., Anyaoku, V., Johnston, D. G., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02262.x · Cited by 141 · see citing works
Moran, L., Gibson-Helm, M., Teede, H., & Deeks, A. (2010) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674820903477593 · Cited by 127 · see citing works
Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome
Ornstein, R. M., Copperman, N. M., & Jacobson, M. S. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.01.002 · Cited by 82 · see citing works
Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls
Shishehgar, F., Ramezani Tehrani, F., Mirmiran, P., Hajian, S., Baghestani, A. R., & Moslehi, N. (2016) · Global Journal of Health Science · doi:10.5539/gjhs.v8n9p302 · Cited by 49 · see citing works
Self-citationRouhani, M. H., Kelishadi, R., Hashemipour, M., Esmaillzadeh, A., & Azadbakht, L. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.5.385 · Cited by 23 · see citing works
Flagged first, then by citations
Research works printed but not linked: 28
- [1]Skiba MA Islam RM Bell RJ1, Davis SR. understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 2018 24 6 694 709 10.1093/humupd/dmy022 30059968 · DOI
- [3]Thomson RL Buckley JD Noakes M Clifton PM Norman RJ Brinkworth GD The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome J Clin Endocrinol Metab 2008 93 9 3373 3380 10.1210/jc.2008-0751 18583464 · DOI · Paper page
- [4]Augustin LS Kendall CW Jenkins DJ Willett WC Astrup A Barclay AW Björck I Brand-Miller JC Brighenti F Buyken AE Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC) Nutr Metab Cardiovasc Dis 2015 25 795e815 10.1016/j.numecd.2015.05.005 26160327 · DOI · Paper page
- [5]Szczuko M Zapałowska-Chwyć M Maciejewska D Drozd A Starczewski A Stachowska E High glycemic index diet in PCOS patients. The analysis of IGF I and TNF-α pathways in metabolic disorders Med Hypotheses 2016 96 42 47 10.1016/j.mehy.2016.09.016 27959274 · DOI
- [6]Di Pino A Currenti W Urbano F Scicali R Piro S Purrello F Rabuazzo AM High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes Nutr Metab Cardiovasc Dis 2017 27 11 978 984 10.1016/j.numecd.2017.06.014 28958695 · DOI
- [9]Japur CC Diez-Garcia RW Oliveira Penaforte FR Imbalance between postprandial ghrelin and insulin responses to an ad libitum meal in obese women with polycystic ovary syndrome Reprod Sci 2014 21 8 1020 1026 10.1177/1933719114522521 24520086 PMC4126217 · DOI
- [11]Jeanes Y Barr S Sharp K Reeves S Eating behaviours and BMI in women with polycystic ovary syndrome Proc Nutr Soc 2010 69 OCE1 E57 10.1017/S002966510999245X · DOI
- [12]The Rotterdam EA-SPCWG Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 2004 81 1 19 25 10.1016/j.fertnstert.2003.10.004 14711538 · DOI · Paper page
- [13]Foster-Powell K Holt SH Brand-Miller JC International table of glycemic index and glycemic load values Am J Clin Nutr 2002 76 5 56 10.1093/ajcn/76.1.5 12081815 · DOI · Paper page
- [16]Hatch R Rosenfield RL Kim MH Tredway D Hirsutism: implications, etiology, and management Am J Obstet Gynecol 1981 140 7 815 830 10.1016/0002-9378(81)90746-8 7258262 · DOI
- [19]Blay SL Aguiar JV Passos IC Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis Europsychiatr Dis Treat 2016 8 12 2895 2903 10.2147/NDT.S91700 PMC5108561 27877043 · DOI
- [20]Churchill SJ Wang ET Bhasin G Alexander C Bresee C Pall M Azziz R Mathur R Pisarska MD Basal metabolic rate in women with PCOS compared to eumenorrheic controls Clin Endocrinol 2015 83 3 384 388 10.1111/cen.12740 25660380 · DOI
- [21]Radulian G Rusu E Dragomir A Posea M Metabolic effects of low glycaemic index diets Nutr J 2009 8 5 10.1186/1475-2891-8-5 19178721 PMC2654909 · DOI · Paper page
- [23]Marsh KA Steinbeck KS Atkinson FS Petocz P Brand-Miller JC Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome Am J Clin Nutr 2010 92 83 92 10.3945/ajcn.2010.29261 20484445 · DOI · Paper page
- [24]Tiikkainen M Bergholm R Vehkavaara S Rissanen A Hakkinen AM Tamminen M Teramo K YkiJarvinen H Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content Diabetes 2003 52 701 707 10.2337/diabetes.52.3.701 12606511 · DOI · Paper page
- [25]Reaven G Segal K Hauptman J Boldrin M Lucas C Effect of orlistat assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X Am J Cardiol 2001 87 827 831 10.1016/S0002-9149(00)01521-6 11274935 · DOI
- [26]Herriot AM Whitcroft S Jeanes Y An retrospective audit of patients with polycystic ovary syndrome: the effects of a reduced glycaemic load diet J Hum Nutr Diet 2008 21 337 345 10.1111/j.1365-277X.2008.00890.x 18721400 · DOI · Paper page
- [27]Moran LJ Noakes M Wittert GA Clifton PM Norman RJ Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome Reprod Biomed 2012 25 5 500 503 10.1016/j.rbmo.2012.07.013 22995747 · DOI
- [28]Lo JC Feigenbaum SL Yang J Pressman AR Selby JV Go AS Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome J Clin Endocrinol Metab 2006 91 4 1357 1363 10.1210/jc.2005-2430 16434451 · DOI
- [30]Phy JL Pohlmeier AM Cooper JA Watkins P Spallholz J Harris KS Berenson AB Boylan M Low starch/low dairy diet results in successful treatment of obesity and co-morbidities linked to polycystic ovary syndrome (PCOS) Obes Weight Loss Ther 2015 5 2 PMC4516387 26225266
- [31]Diamanti-Kandarakis E Dunaif A Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications Endocr Rev 2012 33 981 103 10.1210/er.2011-1034 23065822 PMC5393155 · DOI · Paper page
- [33]Lass N Kleber M Winkel K Wunsch R Reinehr TH Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls J Clin Endocrinol Metab 2011 96 11 3533 3540 10.1210/jc.2011-1609 21880803 · DOI · Paper page
- [34]Moran LJ Noakes M Clifton PM Tomlinson L Norman RJ Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome J Clin Endocrinol Metab 2003 88 2 812 819 10.1210/jc.2002-020815 12574218 · DOI · Paper page
- [35]Kwon HH Yoon JY Hong JS Jung JY Park MS Suh DH Clinical and histological effect of a low Glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial Acta Derm Venereol 2012 92 241 246 10.2340/00015555-1346 22678562 · DOI · Paper page
- [36]Melnik BC John SM Plewig G Acne: risk Indicator for increased body mass index and insulin resistance Acta Derm Venereol 2013 93 644 649 10.2340/00015555-1677 23975508 · DOI
- [37]Seyam E Hefzy E Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome Gynecol Endocrinol 2018 34 12 1073 1080 10.1080/09513590.2018.1490405 30044162 · DOI
- [38]Seyam E Al Gelany S Abd A Ghaney A Mohamed MAA Youseff AM Ibrahim EM Khalifa EM Hefzy E Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome Gynecol Endocrinol 2018 34 7 589 596 10.1080/09513590.2017.1418853 29258367 · DOI
- [39]Scicali R Di Pino A Ferrara V Urbano F Piro S Rabuazzo AM Purrello F New treatment options for lipid-lowering therapy in subjects with type 2 diabetes Acta Diabetol 2018 55 3 209 218 10.1007/s00592-017-1089-4 29260404 · DOI
Cited by
Sorted by citations
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521 · see citing works
Herbert, S., & Woolf, K. (2023) · Nutrients · doi:10.3390/nu15245069 · Cited by 15 · see citing works
“…of these studies, similar to many of the other studies included in this review, include the lack of a control group [97,98], different measures of cardiometabolic risk [96], and the inability to determine what is driving the relationship of the improvement in cardiometabolic risk factors.”
BackgroundResultLe, S. T., & Haubrick, K. (2021) · Journal of Food Studies · doi:10.5296/jfs.v10i1.18609 · Cited by 6 · see citing works
“The targeted macronutrient in Shishehgar et al. (2019) was 50% energy from carbohydrate with low to medium glycemic index value, 20% of protein and 30% from fat.”
BackgroundMethodInfluentialNutritional perspective of polycystic ovarian syndrome: A review study
Tripathi, S., Singh, M., Jain, M., & Khatoon, S. (2020) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2020.03.006 · Cited by 6 · see citing works
- Authors
- Shishehgar, F., Mirmiran, P., Rahmati, M., Tohidi, M., & Ramezani Tehrani, F.
- Affiliations
- Islamic Azad University, Tehran (IR)
- Research Institute for Endocrine Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Venue
- BMC Endocrine Disorders
- Published
- 2019-09-02
- Volume
- 19
- Issue
- 1
- Pages
- 93-93
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC6720418
- OpenAlex
- W2971934744
- Cited by
- 59
- References
- 10
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 8 · 2023: 15 · 2022: 10 · 2021: 11 · 2020: 5
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
- Core Research for Evolutional Science and Technology
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology › Diet and metabolism studies
- Keywords
- polycystic ovary syndrome, low glycemic index diet, caloric restriction, weight loss, insulin resistance, testosterone, sex hormone-binding globulin, free androgen index, menstrual irregularity, acne, overweight women, dietary intervention
- MeSH terms
- Adolescent, Adult, Diet, Reducing, Female, Follow-Up Studies, Humans, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Prognosis, Weight Loss, Body Mass Index, Case-Control Studies, Caloric Restriction, Glycemic Index, Overweight, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review